Araceli Tejada-Lopez

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.

Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.

Journal: International journal of biological sciences

Published: February 22, 2025

Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy.

Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy.

Journal: Pharmaceutics

Published: December 19, 2024

Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy.

Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy.

Journal: Molecular cancer

Published: January 18, 2024

Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells.

Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 30, 2023

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression.

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression.

Journal: International journal of biological sciences

Published: September 09, 2022

Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer.

Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer.

Journal: Pharmaceutics

Published: January 12, 2022

Antioxidants for the Treatment of Breast Cancer: Are We There Yet?

Antioxidants for the Treatment of Breast Cancer: Are We There Yet?

Journal: Antioxidants (Basel, Switzerland)

Published: December 30, 2020

Drug Repurposing for Triple-Negative Breast Cancer.

Drug Repurposing for Triple-Negative Breast Cancer.

Journal: Journal of personalized medicine

Published: September 24, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026